Results 91 to 100 of about 32,793 (264)

Invasive Meningococcal Disease in a Patient With Complement 7 Deficiency

Journal of General and Family Medicine, Volume 26, Issue 6, Page 646-649, November 2025.
ABSTRACT Neisseria meningitidis can cause invasive meningococcal disease (IMD). Individuals with primary complement deficiencies are at a higher risk of developing IMD. However, cases of IMD associated with complement deficiency have rarely been reported in Japan.
Hiroaki Nishioka, Kazuki Maegawa, Shigeo Hara   +2 more
wiley   +1 more source

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease

Therapeutics and Clinical Risk Management, 2008
Sanford R KimmelUniversity of Toledo College of Medicine, Department of Family Medicine, Toledo, OH, USAAbstract: Invasive meningococcal disease occurs worldwide causing an estimated 50,000–135,000 deaths each year in addition to significant ...
Sanford R Kimmel
doaj  

Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development

Human Vaccines & Immunotherapeutics, 2018
The control of meningitis, meningococcemia and other infections caused by Neisseria meningitidis is a significant global health challenge. Substantial progress has occurred in the last twenty years in meningococcal vaccine development and global ...
A. W. Dretler, N. G. Rouphael, D. S. Stephens   +2 more
doaj   +1 more source

Meningococcal Vaccines: Current Status and Emerging Strategies

Vaccines, 2018
Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world.
Pumtiwitt C. McCarthy, Abeer Sharyan, Laleh Sheikhi Moghaddam   +2 more
doaj   +1 more source

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study

Human Vaccines & Immunotherapeutics, 2020
Neisseria meningitidis can lead to invasive meningococcal disease to which young children are particularly vulnerable. We assessed the immunogenicity and safety of Sanofi Pasteur’s investigational quadrivalent (serogroups A, C, Y, and W) meningococcal ...
Timo Vesikari, Ray Borrow, Aino Forsten, Helen Findlow, Mandeep S. Dhingra, Emilia Jordanov   +5 more
doaj   +1 more source

Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N. lactamica. [PDF]

, 2011
Both Neisseria meningitidis and the closely related bacterium Neisseria lactamica colonise human nasopharyngeal mucosal surface, but only N. meningitidis invades the bloodstream to cause potentially life-threatening meningitis and septicaemia.
Hibberd, Martin L, Kroll, J Simon, Langford, Paul R, Li, Ming-Shi, Wong, Hazel En En   +4 more
core   +1 more source

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16. [PDF]

, 2019
Background In 1999, the United Kingdom (UK) was the first country to introduce meningococcal group C (MenC) conjugate vaccination. This vaccination programme has evolved with further understanding, new vaccines and changing disease epidemiology.
Bazan, Borrow, Campbell, Farrington, Folaranmi, Gray, Hill, Hill, Huson, Ishola, Jolley, Kupferschmidt, Ladhani, Ladhani, Lucidarme, Lucidarme, Maiden, Maslanka, Miglietta, Miller, Neal, Nunes, Osborne, Parent du Chatelet, Ramsay, Simmons, Stoof, Sáfadi, Taha, Trotter, Trotter, Tzeng, Whittaker   +32 more
core   +1 more source

Trends in Meningococcal Disease in the United States Military, 1971–2010

Emerging Infectious Diseases, 2012
Meningococci have historically caused extensive illness among members of the United States military. Three successive meningococcal vaccine types were used from 1971 through 2010; overall disease incidence dropped by >90% during this period.
Michael P. Broderick, Dennis J. Faix, Christian J. Hansen, Patrick J. Blair   +3 more
doaj   +1 more source

Potential benefits of using a multicomponent vaccine for prevention of serogroup B meningococcal disease

International Journal of Infectious Diseases, 2019
Meningococcal serogroup B (MenB) has become the main cause of invasive meningococcal disease in industrialized countries in recent years. The diversity of MenB strains and poor immunogenicity of the MenB capsular polysaccharide have made vaccine ...
Philip S. Watson, Patricia L. Novy, Leonard R. Friedland   +2 more
doaj   +1 more source

Vaccine implementation: Alaska 2017 [PDF]

, 2017
Bacterial meningitis is a serious disease that causes permanent dysfunction or death; adolescents and young adults carry the greatest risk. The national Advisory Committee on Immunization Practices (ACIP) has released vaccine recommendations that include
Hulstine, Amanda
core